financetom
Business
financetom
/
Business
/
Tesla's sales in key European markets plunge in April
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's sales in key European markets plunge in April
May 26, 2025 12:01 AM

COPENHAGEN, May 2 (Reuters) - Tesla sales in

some European markets fell sharply in April, in an acceleration

of a trend seen since the beginning of the year for Elon Musk's

EV brand, as Europeans buy more Chinese cars and some protest

against his political views.

Tesla's new car sales in April fell by 80.7% in Sweden,

national data showed on Friday, a day after Denmark recorded a

67.2% drop in Tesla sales and France reported a 59.4% fall, its

fourth straight month of sales contraction.

In Sweden, this was the lowest figure since October 2022,

when 43 new Teslas were registered, data from Mobility Sweden

showed.

The group's European sales dropped 28.2% in March as it

faces a number of challenges in the continent. Tesla is facing

increased competition from traditional automaker rivals, while

new Chinese entrants are launching new and often cheaper EVs.

Musk's embrace of far-right politics in Europe has also led

to protests against the billionaire CEO and the company, as well

as vandalism at its showrooms and charging stations across the

U.S. and Europe.

Other European countries, including Italy and Norway, will

release April car sales data on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Shares Fall After Early Trial Update on mRNA-4359 Cancer Vaccine Combination
Moderna Shares Fall After Early Trial Update on mRNA-4359 Cancer Vaccine Combination
Oct 17, 2025
03:32 PM EDT, 10/17/2025 (MT Newswires) -- Moderna ( MRNA ) shares were down almost 5% in recent trading on Friday after management provided an update on the company's immunotherapy pipeline and presented trial data evaluating its mRNA-4359 cancer vaccine together with pembrolizumab, according to a FactSet transcript of Moderna's ( MRNA ) oncology investor event. The company said Monday...
California takes action against plastic bag makers over recycling claims
California takes action against plastic bag makers over recycling claims
Oct 17, 2025
WASHINGTON (Reuters) -The state of California announced a lawsuit against three major plastic bag producers and reached a settlement with four other manufacturers on Friday after concluding an investigation into their false claims that these bags were recyclable. California Attorney General Rob Bonta announced a lawsuit against Novolex Holdings LLC, Inteplast Group Corp, and Mettler Packaging LLC alleging violations of California's...
Exclusive-KKR-backed FiberCop files complaint with EU over alleged Italy's aid to rival, sources say
Exclusive-KKR-backed FiberCop files complaint with EU over alleged Italy's aid to rival, sources say
Oct 17, 2025
MILAN (Reuters) -KKR-backed telecom network firm FiberCop has filed a complaint with the European Commission, alleging that Italy provided state aid to rival Open Fiber in breach of EU competition rules, three sources with knowledge of the matter said. The complaint, which alleges Italy altered competition in its ultra-broadband market, escalates a standoff between KKR and the Rome government, which...
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
Oct 17, 2025
Oct 17 (Reuters) - * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL Source text: https://www.ftc.gov/news-events/news/press-releases/2025/10/ftc-approves-final-divestiture-order-synopsys-ansys-deal Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved